T1	PROC 44 63	Evaluar la eficacia
#1	AnnotatorNotes T1	C1707887; Efficacy Study; Research Activity
T2	CHEM 88 96	albúmina
#2	AnnotatorNotes T2	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T3	PROC 110 124	hospitalizados
#3	AnnotatorNotes T3	C0019993; Hospitalization; Health Care Activity
T4	DISO 129 163	neumonía adquirida en la comunidad
#4	AnnotatorNotes T4	C0694549; Community acquired pneumonia; Disease or Syndrome
T5	PROC 195 310	Ensayo clínico de fase III, con asignación aleatoria, controlado, abierto y multicéntrico, con dos grupos paralelos
T6	PROC 317 336	evaluar la eficacia
#5	AnnotatorNotes T6	C1707887; Efficacy Study; Research Activity
T7	CHEM 361 369	albúmina
#6	AnnotatorNotes T7	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T8	PROC 383 397	hospitalizados
#7	AnnotatorNotes T8	C0019993; Hospitalization; Health Care Activity
T9	DISO 402 436	neumonía adquirida en la comunidad
#8	AnnotatorNotes T9	C0694549; Community acquired pneumonia; Disease or Syndrome
T10	PROC 497 511	hospitalizados
#9	AnnotatorNotes T10	C0019993; Hospitalization; Health Care Activity
T11	DISO 516 550	Neumonía adquirida en la comunidad
#10	AnnotatorNotes T11	C0694549; Community acquired pneumonia; Disease or Syndrome
T12	DISO 552 555	NAC
#11	AnnotatorNotes T12	C0694549; Community acquired pneumonia; Disease or Syndrome
T13	DISO 582 616	Neumonía adquirida en la comunidad
#12	AnnotatorNotes T13	C0694549; Community acquired pneumonia; Disease or Syndrome
T14	DISO 618 621	NAC
#13	AnnotatorNotes T14	C0694549; Community acquired pneumonia; Disease or Syndrome
T15	PROC 703 717	hospitalizados
#14	AnnotatorNotes T15	C0019993; Hospitalization; Health Care Activity
T16	PROC 722 733	diagnóstico
#15	AnnotatorNotes T16	C0011900; Diagnosis; Diagnostic Procedure
T17	DISO 737 740	NAC
#16	AnnotatorNotes T17	C0694549; Community acquired pneumonia; Disease or Syndrome
T18	DISO 758 773	hipoalbuminemia
#17	AnnotatorNotes T18	C0239981; Hypoalbuminemia; Disease or Syndrome
T19	CHEM 775 783	albúmina
#18	AnnotatorNotes T19	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T20	ANAT 784 790	sérica
#19	AnnotatorNotes T20	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T21	PROC 944 968	consentimiento informado
#20	AnnotatorNotes T21	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T22	PROC 1102 1118	test de embarazo
#21	AnnotatorNotes T22	C0032976; Pregnancy Tests; Diagnostic Procedure
T23	DISO 1123 1139	Inmunodeprimidos
#22	AnnotatorNotes T23	C0085393; Immunocompromised Host; Finding
T24	PROC 1152 1165	quimioterapia
#23	AnnotatorNotes T24	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T25	PROC 1168 1180	radioterapia
#24	AnnotatorNotes T25	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T26	CHEM 1212 1237	fármacos inmunosupresores
#25	AnnotatorNotes T26	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T27	CHEM 1254 1265	corticoides
#26	AnnotatorNotes T27	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T28	PROC 1325 1367	trasplante de progenitores hematopoyéticos
#27	AnnotatorNotes T28	C0472699; Hemopoietic stem cell transplant; Therapeutic or Preventive Procedure
T29	ANAT 1339 1367	progenitores hematopoyéticos
#28	AnnotatorNotes T29	C0018956; Hematopoietic stem cells; Cell
T30	PROC 1369 1396	trasplante de órgano sólido
#29	AnnotatorNotes T30	C0730400; Solid organ transplant; Therapeutic or Preventive Procedure
T31	PROC 1416 1419	CD4
#30	AnnotatorNotes T31	C0243009; CD4 Positive T Lymphocytes count; Laboratory Procedure
T32	DISO 1462 1495	Insuficiencia cardíaca congestiva
#31	AnnotatorNotes T32	C0018802; Congestive heart failure; Disease or Syndrome
T33	DISO 1524 1543	Reacciones adversas
#32	AnnotatorNotes T33	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T34	CHEM 1559 1567	albúmina
#33	AnnotatorNotes T34	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T35	CHEM 1585 1596	excipientes
#34	AnnotatorNotes T35	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T36	CHEM 1669 1677	albúmina
#35	AnnotatorNotes T36	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T37	DISO 1692 1709	cirrosis hepática
#36	AnnotatorNotes T37	C0023890; Liver Cirrhosis; Disease or Syndrome
T38	DISO 1714 1721	ascitis
#37	AnnotatorNotes T38	C0003962; Ascites; Disease or Syndrome
T39	DISO 1723 1747	síndrome de malabsorción
#38	AnnotatorNotes T39	C0024523; Malabsorption Syndrome; Disease or Syndrome
T40	DISO 1749 1767	síndrome nefrótico
#39	AnnotatorNotes T40	C0027726; Nephrotic Syndrome; Disease or Syndrome
T41	PROC 1794 1808	ensayo clínico
#40	AnnotatorNotes T41	C0008976; Clinical Trials; Research Activity
T42	PROC 1812 1823	tratamiento
#41	AnnotatorNotes T42	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T43	PROC 70 84	administración
#42	AnnotatorNotes T43	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T44	PROC 343 357	administración
#43	AnnotatorNotes T44	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T45	DISO 479 496	hipoalbuminémicos
T46	PROC 775 790	albúmina sérica
#44	AnnotatorNotes T46	C0523465; Serum albumin measurement; Laboratory Procedure
T47	ANAT 1383 1396	órgano sólido
T48	DISO 1408 1411	HIV
T49	DISO 1441 1447	Muerte
#45	AnnotatorNotes T49	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T50	ANAT 1476 1484	cardíaca
#46	AnnotatorNotes T50	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T51	PROC 1651 1665	administración
#47	AnnotatorNotes T51	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T52	ANAT 1701 1709	hepática
#48	AnnotatorNotes T52	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T53	Date 12 16	2018
T54	LIVB 100 109	pacientes
#49	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	LIVB 373 382	pacientes
#50	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	LIVB 469 478	Pacientes
#51	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 652 669	Pacientes adultos
#52	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T58	LIVB 690 701	ambos sexos
#53	AnnotatorNotes T58	C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T59	Age 671 684	18 años o más
T60	LIVB 744 753	Pacientes
#54	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T63	LIVB 806 812	sujeto
#55	AnnotatorNotes T63	C0681850; Study Subject; Group
T64	LIVB 817 836	representante legal
#56	AnnotatorNotes T64	C4288823; Legal Representative for the Study; Human
T65	LIVB 839 847	familiar
#57	AnnotatorNotes T65	C0080103; Relative (related person); Family Group
T66	DISO 872 883	incapacidad
#58	AnnotatorNotes T66	C0231172; handicapping condition; Finding
T67	LIVB 888 894	sujeto
#59	AnnotatorNotes T67	C0681850; Study Subject; Group
T68	PHYS 998 1006	Embarazo
#60	AnnotatorNotes T68	C0032961; Pregnancy; Organism Function
T69	PHYS 1011 1020	lactancia
#61	AnnotatorNotes T69	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T70	LIVB 1025 1047	mujeres en edad fértil
#62	AnnotatorNotes T70	C4324275; Woman of childbearing potential; Population Group
T71	Age 1036 1047	edad fértil
T73	Neg_cue 1048 1061	se descartará
T75	PHYS 1080 1089	gestación
#63	AnnotatorNotes T75	C0032961; Pregnancy; Organism Function
T76	Duration 1184 1203	los 90 días previos
T77	Duration 1243 1250	crónico
#64	AnnotatorNotes T77	C0205191; chronic; Temporal Concept
T78	Dose 1271 1292	dosis mínima de 15 mg
T80	Frequency 1292 1296	/día
T81	Duration 1300 1323	las últimas dos semanas
T82	LIVB 1398 1407	pacientes
#65	AnnotatorNotes T82	C0030705; Patients; Patient or Disabled Group
T84	Duration 1827 1849	los tres meses previos
T85	LIVB 154 163	comunidad
#66	AnnotatorNotes T85	C0009462; Community; Group
T86	LIVB 427 436	comunidad
#67	AnnotatorNotes T86	C0009462; Community; Group
T87	LIVB 541 550	comunidad
#68	AnnotatorNotes T87	C0009462; Community; Group
T88	LIVB 607 616	comunidad
#69	AnnotatorNotes T88	C0009462; Community; Group
T89	PHYS 1110 1118	embarazo
#70	AnnotatorNotes T89	C0032961; Pregnancy; Organism Function
T91	PHYS 1352 1367	hematopoyéticos
#71	AnnotatorNotes T91	C0018951; Hematopoiesis; Organ or Tissue Function
T61	PROC 1515 1519	NYHA
#72	AnnotatorNotes T61	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
A1	Population_data T57 Age
A2	Assertion T75 Negated
A3	Assertion T89 Negated
A4	Status T24 History_of
A5	Status T25 History_of
A6	Status T30 History_of
A7	Status T28 History_of
A8	Status T33 History_of
#73	AnnotatorNotes T5	C0282461; Phase 3 Clinical Trials; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity + C1709323; Open Label Study; Research Activity + C1096776; Multicenter Study; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#74	AnnotatorNotes T45	C0239981; Hypoalbuminemia; Disease or Syndrome
#75	AnnotatorNotes T48	C4759637; HIV positive status; Finding
#76	AnnotatorNotes T47	C0440790;  Solid organ; Body Part, Organ, or Organ Component
R1	Negation Arg1:T73 Arg2:T75	
R2	Negation Arg1:T73 Arg2:T89	
R3	Used_for Arg1:T2 Arg2:T43	
R4	Experiences Arg1:T54 Arg2:T43	
R5	Overlap Arg1:T43 Arg2:T3	
R6	Experiences Arg1:T54 Arg2:T4	
R7	Overlap Arg1:T3 Arg2:T4	
R8	Used_for Arg1:T7 Arg2:T44	
R9	Experiences Arg1:T55 Arg2:T44	
R10	Experiences Arg1:T55 Arg2:T8	
R11	Overlap Arg1:T44 Arg2:T8	
R12	Experiences Arg1:T55 Arg2:T9	
R13	Overlap Arg1:T8 Arg2:T9	
R14	Experiences Arg1:T56 Arg2:T45	
R16	Experiences Arg1:T56 Arg2:T11	
R17	Experiences Arg1:T56 Arg2:T10	
R18	Experiences Arg1:T56 Arg2:T12	
R19	Overlap Arg1:T45 Arg2:T11	
R20	Overlap Arg1:T45 Arg2:T12	
R23	Has_Age Arg1:T57 Arg2:T59	
R24	Has_Age Arg1:T58 Arg2:T59	
R25	Experiences Arg1:T57 Arg2:T15	
R26	Experiences Arg1:T57 Arg2:T17	
R27	Experiences Arg1:T60 Arg2:T18	
R28	Experiences Arg1:T60 Arg2:T46	
R29	Location_of Arg1:T20 Arg2:T46	
T62	Result_or_Value 791 798	≤30 g/L
R30	Has_Result_or_Value Arg1:T46 Arg2:T62	
R32	Experiences Arg1:T63 Arg2:T66	
R33	Experiences Arg1:T67 Arg2:T66	
T72	Observation 899 931	gravedad de la situación clínica
R34	Experiences Arg1:T67 Arg2:T72	
R35	Causes Arg1:T72 Arg2:T66	
R36	Experiences Arg1:T63 Arg2:T72	
R37	Has_Age Arg1:T70 Arg2:T71	
R38	Experiences Arg1:T70 Arg2:T75	
R39	Experiences Arg1:T70 Arg2:T22	
R40	Experiences Arg1:T70 Arg2:T89	
R41	Causes Arg1:T24 Arg2:T23	
R42	Causes Arg1:T25 Arg2:T23	
R43	Causes Arg1:T26 Arg2:T23	
R44	Causes Arg1:T27 Arg2:T23	
R45	Has_Duration_or_Interval Arg1:T27 Arg2:T77	
R46	Overlap Arg1:T25 Arg2:T76	
R47	Overlap Arg1:T24 Arg2:T76	
R48	Has_Dose_or_Strength Arg1:T27 Arg2:T78	
R49	Has_Frequency Arg1:T27 Arg2:T80	
R50	Overlap Arg1:T27 Arg2:T81	
R52	Causes Arg1:T28 Arg2:T23	
R53	Causes Arg1:T30 Arg2:T23	
R54	Experiences Arg1:T82 Arg2:T48	
R55	Causes Arg1:T48 Arg2:T23	
R56	Experiences Arg1:T82 Arg2:T31	
T74	Result_or_Value 1420 1436	inferiores a 200
R57	Has_Result_or_Value Arg1:T31 Arg2:T74	
R58	Experiences Arg1:T82 Arg2:T30	
R59	Experiences Arg1:T82 Arg2:T28	
R60	Experiences Arg1:T82 Arg2:T27	
R61	Experiences Arg1:T82 Arg2:T26	
R62	Experiences Arg1:T82 Arg2:T25	
R63	Experiences Arg1:T82 Arg2:T24	
R64	Experiences Arg1:T82 Arg2:T23	
T79	Quantifier_or_Qualifier 1140 1146	graves
#77	AnnotatorNotes T79	C1547227; Severe - Severity of Illness Code; Intellectual Product
R65	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T79	
T83	Result_or_Value 1497 1508	clase 3 o 4
R66	Has_Result_or_Value Arg1:T61 Arg2:T83	
R67	Location_of Arg1:T50 Arg2:T32	
R69	Causes Arg1:T34 Arg2:T33	
R70	Causes Arg1:T35 Arg2:T33	
T90	Observation 1441 1457	Muerte inminente
#78	AnnotatorNotes T90	C2363727; Death imminent; Finding
R71	Used_for Arg1:T36 Arg2:T51	
R72	Location_of Arg1:T52 Arg2:T37	
R73	Overlap Arg1:T37 Arg2:T38	
T92	Observation 1772 1808	Participación en otro ensayo clínico
R74	Overlap Arg1:T42 Arg2:T84	
R75	Overlap Arg1:T41 Arg2:T84	
R76	Overlap Arg1:T92 Arg2:T84	
R77	Experiences Arg1:T54 Arg2:T3	
R21	Experiences Arg1:T82 Arg2:T91	
A9	Assertion T72 Hypothetical
A10	Experiencer T67 Patient
A11	Assertion T66 Hypothetical
A12	Experiencer T63 Patient
A13	Experiencer T64 Other
A14	Experiencer T65 Family_member
A15	Experiencer T60 Patient
A16	Experiencer T57 Patient
A17	Experiencer T58 Patient
A18	Experiencer T70 Patient
A19	Experiencer T54 Patient
A20	Experiencer T85 Other
A21	Experiencer T55 Patient
A22	Experiencer T86 Other
A23	Experiencer T87 Other
A24	Experiencer T56 Patient
A25	Experiencer T88 Other
A26	Experiencer T82 Patient
A27	Status T49 Future
